It selectively stimulates adrenergic β1-receptors, resulting in sustained enhancement of myocardial contractility, with minimal effects on β2- and α-receptors, thus not affecting heart rate. It dilates coronary arteries and is less likely to induce arrhythmias compared to digitalis. It is used in the treatment of chronic heart failure.